Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      AI and Biotech Pioneer Alex Zhavoronkov Commits His Life, Estate to Longevity for All


      News provided by

      Longevity Science Foundation

      Oct 25, 2022, 08:27 ET

      Share this article

      Share this article


      Zhavoronkov's "Longevity Pledge" invites the world's 1% and longevity enthusiasts to make longer, healthier human lifespans a reality for everyone

      DUBAI, United Arab Emirates, Oct. 25, 2022 /PRNewswire/ -- Today, the artificial intelligence, biotech and longevity pioneer Alex Zhavoronkov, PhD, has publicly called for the world's most successful founders, altruistic billionaires, and dedicated longevity pioneers to join him in his unorthodox and principled "Longevity Pledge."

      Alex Zhavoronkov, PhD, is the founder and Chief Longevity Officer of Deep Longevity, the founder and CEO of Insilico Medicine, and an adjunct professor at the esteemed Buck Institute for Research on Aging. He serves on the Visionary Board of the Longevity Science Foundation, is part of the advisory board for longevity and biotech venture capital firm LongeVC and advises multiple other non-profits and startups working in longevity biotechnology. He is a renowned artificial intelligence, biotechnology, and longevity expert, founder, and scientist, hailing from Canada and Latvia. 

      Today, Alex Zhavoronkov formally announced his personal "Longevity Pledge." Through this pledge,  Zhavoronkov committed all of his wealth and resources, as well as all of his remaining time to supporting and developing research and clinical solutions for extending healthy productive longevity for everyone on the planet.

      "Making productive longevity, or the ability to live a longer, healthier life, is the most altruistic cause you can support," said Alex Zhavoronkov. "If we could extend everyone's life by just one more high-quality, healthy year, our world would benefit from roughly 8 billion more impactful years in a few generations. These years could mean thousands of new medical and scientific discoveries, impactful action on climate change, and more. This is no time to waste. I hope my example will motivate people with similar backgrounds to not only commit their wealth, but also their intellect, skills, and ingenuity to this strangely underappreciated cause."

      Alex Zhavoronkov's personal Longevity Pledge included:

      -  Committing his entire fortune (including future earnings) to the cause of human longevity

      -  100% of his time to advising, founding, creating and pursuing longevity initiatives 

      -  Invest solely in companies with the potential to extend healthy, productive life, forming a global longevity ecosystem. These companies can grow, become sustainable, give rise to other companies, and return profits that can be reinvested in other longevity enterprises.

      The full pledge can be read here.

      By inviting others to join the Longevity Pledge, Alex Zhavoronkov believes that four significant breakthroughs for human longevity will be accelerated from approaching release in 20+ years to broadly available in 5 years:

      -  The development of AI-powered drug discovery platforms that will significantly derisk, accelerate, and democratize the discovery of novel therapeutics. The cost of drug discovery and development may exceed $3 billion to launch just one novel drug on the market. The process from disease hypothesis and target discovery to launch of the drug in the clinic can take at least 12 years and fails 99% of the time (source: Insilico Medicine, founded by Alex Zhavoronkov, which is at the forefront of this field and utilizes artificial intelligence, robotics and its global team to accelerate drug discovery).

      -  Personalized medicine, treatment and drugs: Develop fully automated systems that can customize care to each patient and help discover novel therapeutics and therapeutic combinations for individuals.

      -  Cryotherapy/cryobiology and biostasis: Recent advances can allow doctors to freeze and unfreeze organs rapidly, and possibly entire bodies, to enable long-term storage, transport, and even "biostasis" for the terminally ill or irreparably frail.

      -  Artificial intelligence and robotics-powered hospitals: All of the above breakthroughs support the creation of entirely new research and clinical infrastructure for medical care and repair. Creating an AI/robotics-driven preventive and regenerative research hospital is Alex Zhavoronkov's ultimate goal.

      To learn more, please visit Longevity.Pledge.

      About Alex Zhavoronkov, PhD

      Professor Zhavoronkov is a Latvian and Canadian scientist and founder. He received his bachelor's degrees from Queen's University in Canada. After graduating, he began his career in the telecommunications and graphics processing unit (GPU) semiconductor industry, which catalyzed his interest in artificial intelligence and neural networks. In 2004, he decided to pursue a career in aging and longevity biotechnology and completed a master's degree at Johns Hopkins University and his PhD in biophysics from MSU.  Afterwards, he directed the bioinformatics and regenerative medicine laboratories at one of the world's largest pediatric hematology, oncology, and immunology research centers. He also worked at and consulted several biotechnology companies and charitable foundations. In 2014, he founded Insilico Medicine, one of the first and largest AI-powered clinical-stage biotechnology companies with end-to-end drug discovery capabilities. At Insilico, he raised over $415 million, developed eight preclinical candidates, and took the aging research- and AI-discovered and AI-designed antifibrotic drug into human clinical trials. He also founded Deep Longevity, which is now part of a publicly-traded Endurance Longevity, a company specializing in aging biomarkers, and published the first aging clocks using deep learning. In 2013, he founded the Aging Research for Drug Discovery (ARDD) conference in Basel, Switzerland, which moved to the University of Copenhagen in 2019. Today it is the largest industry conference in longevity biotechnology. He serves on the Visionary Board of the Longevity Science Foundation and is the head of the advisory board for longevity and biotech venture capital firm LongeVC. Since 2012, he has published more than 160 peer-reviewed articles in Nature, Science, PNAS, and many other top journals. He also wrote a book called "The Ageless Generation," published by Palgrave Macmillan in 2013, which explained the pressing need to accelerate aging research to revive the global economy and avoid economic collapse. Since 2018, he has contributed to Forbes.com on pressing topics in AI and longevity. Learn more about Alex Zhavoronkov and the Longevity Pledge at  www.LongevityPledge.org.

      Press Contact

      Rachel Pipan, [email protected], +31642213615

      SOURCE Longevity Science Foundation

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.